SEC 13F Intelligence

Managers / Q3 2022 · view latest →

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

CIK 0001553936 · SUITES 818-822, 8/F, BANK OF AMERICA, TOWER, 12 HARCOURT ROAD,, HONG KONG, K3, XXXXX · 852-3983-6800

Reported Value
$1.0B
Q3 2022
Positions
26
Filings on Record
29
2019–present window
Filed
Nov 14, 2022
original filing

Summary

Tybourne Capital Management (Hk) Ltd reported $1.0B in U.S.-listed holdings across 26 positions for Q3 2022.

Its largest position, AMZN, represents 8.3% of the portfolio.

Compared with Q2 2022, the fund opened 1 new position and exited 2.

Portfolio Metrics

Turnover
+3.7%
vs prior filed quarter
Top-10 Concentration
+63.5%
share of reported value
Largest Position
+8.3%
Amazon Com Inc Amzn US
New / Exited
1 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.2BQ4 ’18Q1 ’19: $2.6BQ2 ’19: $2.8BQ3 ’19: $2.3BQ4 ’19: $2.6BQ4 ’19Q1 ’20: $2.7BQ2 ’20: $3.3BQ3 ’20: $4.1BQ4 ’20: $4.8BQ4 ’20Q1 ’21: $4.6BQ2 ’21: $4.7BQ3 ’21: $4.0BQ4 ’21: $3.4BQ4 ’21Q1 ’22: $1.7BQ2 ’22: $1.4BQ3 ’22: $1.0BQ4 ’22: $1.0BQ4 ’22Q1 ’23: $993MQ2 ’23: $925MQ3 ’23: $716MQ4 ’23: $671MQ4 ’23Q1 ’24: $585MQ2 ’24: $492MQ3 ’24: $357MQ4 ’24: $398MQ4 ’24Q1 ’25: $24MQ2 ’25: $35MQ3 ’25: $31Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 70.0%ADR: 17.1%Other: 12.8%
  • Common Stock · 70.0% · $729M
  • ADR · 17.1% · $178M
  • Other · 12.8% · $133M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TEAMATLASSIAN CORP -CLASS A (TEAM US)NEW+71.2K71.2K+$15M$15M
NVDANVIDIA CORP (NVDA US)ADDED+199.9K361.5K+$19M$44M
ATLASSIAN CORP PLC-CLASS A (TEAM US)SOLD OUT192.1K0$36M$0
AMLXAMYLYX PHARMACEUTICALS INC (AMLX US)SOLD OUT768.6K0$15M$0
TXNTEXAS INSTRUMENTS INC (TXN US)TRIMMED176.4K112.8K$27M$17M
MDBMONGODB INC (MDB US)TRIMMED55.7K76.3K$19M$15M
SNOWSNOWFLAKE INC-CLASS A (SNOW US)TRIMMED69.1K114.5K$6M$19M
AMZNAMAZON.COM INC (AMZN US)TRIMMED251.6K760.4K$22M$86M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

26 positions
#IssuerClass% PortfolioValueShares
1AMZNAMAZON.COM INC (AMZN US)history →COM8.26%$86M760.4K
2CANADIAN PACIFIC RAILWAY LTD (CP US)COM7.82%$81M1.22M
3MSFTMICROSOFT CORP (MSFT US)history →COM7.51%$78M335.3K
4VVISA INC-CLASS A SHARES (V US)history →COM CL A7.11%$74M416.1K
5MELIMERCADOLIBRE INC (MELI US)history →COM6.31%$66M79.3K
6SPGIS&P GLOBAL INC (SPGI US)history →COM6.07%$63M206.9K
7BEKEKE HOLDINGS INC-ADR (BEKE US)history →SPONSORED ADS5.95%$62M3.53M
8LINDE PLC (LIN US)SHS5.00%$52M192.9K
9ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)history →COM4.79%$50M2.30M
10HTHTH WORLD GROUP LTD (HTHT US)history →SPONSORED ADS4.69%$49M1.45M
11LAM RESEARCH CORP (LRCX US)COM4.38%$46M124.6K
12NVDANVIDIA CORP (NVDA US)history →COM4.22%$44M361.5K
13SESEA LTD-ADR (SE US)history →SPONSORD ADS3.53%$37M655.7K
14QCOMQUALCOMM INC (QCOM US)history →COM2.93%$31M270.1K
15SHOPSHOPIFY INC - CLASS A (SHOP US)history →CL A2.92%$30M1.13M
16STNESTONECO LTD-A (STNE US)history →COM CL A2.72%$28M2.97M
17TWLOTWILIO INC - A (TWLO US)history →CL A2.66%$28M400.2K
18XYZBLOCK INC (SQ US)history →CL A2.50%$26M473.7K
19BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)history →SPONSORED ADS2.33%$24M1.04M
20SNOWSNOWFLAKE INC-CLASS A (SNOW US)history →CL A1.87%$19M114.5K
21TXNTEXAS INSTRUMENTS INC (TXN US)history →COM1.68%$17M112.8K
22MDBMONGODB INC (MDB US)history →CL A1.46%$15M76.3K
23TEAMATLASSIAN CORP -CLASS A (TEAM US)history →CL A1.44%$15M71.2K
24INHIBRX INC (INBX US)COM1.11%$12M645.8K
25LIANYLIANBIO-ADR (LIAN US)SPONSORED ADS0.64%$7M3.30M
26TSHATAYSHA GENE THERAPIES INC (TSHA US)COM SHS0.09%$965,000500.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$31M4Nov 6, 202513F-HRchanges · EDGAR ↗
Q2 2025$35M6Aug 1, 202513F-HRchanges · EDGAR ↗
Q1 2025$24M5May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$398M37Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$357M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$492M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$585M41May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$671M39Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$716M41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$925M49Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$993M49May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B27Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.0B26Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B27Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.7B30May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.4B26Feb 25, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$4.0B24Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$4.7B29Jul 22, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.6B32Apr 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$4.8B31Feb 11, 202113F-HRchanges · EDGAR ↗
Q3 2020$4.1B29Nov 9, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B21Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.7B21May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$2.6B13Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.3B12Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$2.8B13Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$2.6B11May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.2B9Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.